67 results
Page 2 of 4
6-K/A
EX-99.2
6zq9omu ak
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
5:24pm
6-K/A
EX-99.5
5dokayuu5wux7n5
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
5:24pm
6-K
EX-99.2
gklja0 vluv4ttq2ay7n
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
6-K
EX-99.5
d6nimpdyubuktiuk
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
6-K
EX-99.1
ovsenxcsfgp
22 Apr 21
ObsEva Annual General Meeting 2021
6:31am
6-K
EX-1.1
faxnyf1yfoi
8 Sep 20
ObsEva Announces $20.0 Million Underwritten Offering and Concurrent Private Placement
7:40am
6-K
EX-4.1
ji89l6qzvm6ocng3bnb
8 Sep 20
ObsEva Announces $20.0 Million Underwritten Offering and Concurrent Private Placement
7:40am
6-K
EX-4.2
epp9adh9
8 Sep 20
ObsEva Announces $20.0 Million Underwritten Offering and Concurrent Private Placement
7:40am
UPLOAD
csn1pjjwh
8 Aug 19
Letter from SEC
12:00am
F-3
EX-4.6
it3 shzqwd4nnyxhf
7 Aug 19
Shelf registration (foreign)
8:24am
F-3
EX-4.2
kakhg5sbq
7 Aug 19
Shelf registration (foreign)
8:24am